| Name | Title | Contact Details |
|---|
Hill-Rom is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, surgical products and information technology solutions. Hill-Rom`s comprehensive product and service offerings are used by health care providers across the health care continuum and around the world in hospitals, extended care facilities and home care settings to enhance the safety and quality of patient care.
Recovery Force is an innovative medical device company providing healthcare professionals, patients, and athletes with a next-generation mobile compression solution for enhancing circulation. The company has developed a platform technology with the ability to embed shape-changing memory fibers into various types of garments and footwear to produce therapeutic compressions. Recovery Force`s portfolio includes medical devices that will reduce post-operative pain, swelling and wound healing time; treat chronic lymphedema; prevent blood clots (DVT); and alleviate joint pain and sore muscles. The same technology used in healthcare is also available to sports enthusiasts and athletes, providing enhanced circulation during warm-up and recovery to achieve optimal performance.
Telemedicine Solutions, LLC is a Wilmette, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
HeartFlow is a medical technology company transforming the way cardiovascular disease is diagnosed and treated. With our HeartFlow Analysis, a non-invasive personalized cardiac test, physicians are able to make better care decisions for their patients with suspected coronary artery disease--the number one killer of men and women worldwide. HeartFlow is backed by decades of scientific research and development and leverages the latest advancements in technology to help set a new standard of care for diagnosing cardiovascular care worldwide. Cleared for use in the United States, Canada, Europe and Japan and with offices in Redwood City, Austin, London and Japan, HeartFlow`s footprint is growing rapidly. HeartFlow has received more than $240 million dollars in funding in a recent Series E financing round, is pre-IPO and leverages the latest technology including deep learning and computational fluid dynamics. We try to embody the best of both technology and healthcare companies and hire people who are passionate about living our mission to save lives, improve the patient experience and reduce the overall cost of care.
Driven by a belief that results should be quick, accurate, and accessible to all, our device platform aims to redefine the way we test and treat illness.